Health Care & Life Sciences » Biotechnology | Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
18.79 M
Public Float
-
Fennec Pharmaceuticals Inc.
Stock Exchange Toronto Stock Exchange Prices
EPS
CAD0.74
Market Cap
CAD105.95 M
Shares Outstanding
19.9 M
Public Float
-

Profile

Address
Research Triangle Park
Durham North Carolina 27709
United States
Employees -
Website http://www.fennecpharma.com
Updated 07/08/2019
Fennec Pharmaceuticals, Inc. is a small stage biotechnology company, which engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Financials

View All

Rostislav C. Raykov
Chief Executive Officer & Director
Khalid Islam
Chairman